Tasia's research focuses on applying host cell and microbiome profiling techniques in patient-derived samples to identify the immune and microbial drivers of pediatric inflammatory bowel disease. Her work leverages novel microphysiological systems to model intestinal disease in translational contexts, bridging basic discovery with clinical application. She completed her Ph.D. in Biology and Biomedical Sciences at UMass Chan Medical School, where she investigated how the gut microbiome and tuft cells in the colonic epithelium communicate to regulate host defense and immune responses during infection. Her prior experience includes characterization of intestinal host-microbiome interactions, the development of murine intestinal infection models that permit the utilization of anaerobic probiotics, and optimization of bacterially-derived anthelmintic proteins.
